Latest News and Press Releases
Want to stay updated on the latest news?
-
Superluminal Medicines, Inc. announced the formation of its Scientific Advisory Board (SAB).
-
Superluminal Medicines, Inc. announced the closing of a $120 million Series A funding round.
-
Financing led by RA Capital Management with participation from Insight Partners, NVIDIA, and Gaingels Superluminal combines deep biology and chemistry expertise with machine learning built on vast...